Diabetes Clinical Trial
Official title:
eFIcacious-Diabetes Care: a Pilot Study of a Pharmacist-Led Optimization Intervention to Achieve Guideline-based Care for Frail Older Adults
Verified date | October 2023 |
Source | Wake Forest University Health Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this research is to explore whether a pharmacist-led diabetes management program can help optimize diabetes care for older adults. Participation in this study will involve meeting with a pharmacist who works with subjects' doctors, getting some routine bloodwork typical for people with diabetes, and potentially adjusting the subject's diabetes medications to reach American Diabetes Association guidelines. This study aims to bring older adults with diabetes whose measurements and medications are different from the guidelines of the American Diabetes Association into guidelines-based ranges.
Status | Active, not recruiting |
Enrollment | 100 |
Est. completion date | April 2025 |
Est. primary completion date | November 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years and older |
Eligibility | Inclusion Criteria: - Attributed to a Atrium Health Wake Forest Baptist-affiliated Accountable Care Organization - At least 2 consecutive International Classification of Diseases 10th Revision (ICD-10) codes for type two diabetes mellitus in the prior 2 years - Has a calculable Electronic Frailty Index (eFI) score >0.21 - A glycosylated hemoglobin (HbA1c) value <7.5% in the prior 2 years - Currently taking a sulfonylurea or insulin for Type 2 Diabetes Mellitus (T2DM) Exclusion Criteria: - Moderate to severe hearing loss (due to phone interventions) - Diagnosed Alzheimer's disease or related dementia (unable to participate) - Non-English speaking (not all pharmacists speak a second language; subtleties may not be conveyed effectively) - No phone number available for patient (follow up contacts will be by telehealth or phone |
Country | Name | City | State |
---|---|---|---|
United States | Atrium Health Wake Forest Baptist Health | Winston-Salem | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Wake Forest University Health Sciences |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Proportion of subjects who Achieve Glycosylated Hemoglobin (HbA1c) values | Proportion of subjects who achieve target value of HbA1c >7.5% | Month 6 | |
Primary | Change in HbA1c | From Baseline through Month 6 | ||
Primary | Random Glucose Measurements | The study team will track any glucose measurements obtained between initial enrollment and 6-12 months follow up after completion of the intervention, up until a total of 12 months after initial enrollment. This will be reported as a glucose trajectory. | From Baseline through Month 12 | |
Primary | Estimated Change in Out-of-Pocket Costs | Change in diabetes medication cost | From Baseline through Month 6 | |
Primary | Point estimates of Feasibility Measures: Participation/Reach | The proportion of those referred who chose to participate | Month 6 | |
Primary | Point estimates of Feasibility Measures: Number Contacted/Reach | Total number of subjects contacted | Month 6 | |
Primary | Point estimates of Feasibility Measures: Number at Risk/Reach | Total number of patients who meet inclusion/exclusion criteria at each site | Month 6 | |
Primary | Feasibility Measures: Effort Required to Enroll-Number Calls | Number of calls to enroll | Month 6 | |
Primary | Feasibility Measures: Effort Required to Enroll-Average Call Duration | Duration of calls to enroll in minutes. | Month 6 | |
Primary | Point estimates of Feasibility Measure-Number of Visits | Mean and median number of visits with the pharmacist before glucose levels are met. | Month 12 | |
Primary | Point estimates of Feasibility Measures: Time | Time until achieved medication goal per patient will be reported. An achieved medication goal is the following: HbA1c <8 while taking no sulfonylurea or insulin, or HbA1c between 7.5-8 on sulfonylurea or insulin (these would both meet guidelines-based care. | Month 12 | |
Secondary | Rate of Emergency Department Visits and Hospitalizations | Using EHR and Patient Ping, the number of contacts with the Emergency Department (ED) and hospitals (composite) | Baseline through Month 18 | |
Secondary | Number of Hypoglycemic Events Requiring Medical Assistance | Events defined as per action to control cardiovascular risk in diabetes (ACCORD) trial, as hypoglycemic episodes requiring hospitalization or care in an emergency department. | Time Frame: Baseline through Month 18 | |
Secondary | Number of Injurious Falls | Identified by International Classification of Diseases-10th Revision (ICD-10) diagnostic codes; defined as per systolic blood pressure intervention trial (SPRINT) as falls requiring hospitalization or care in an emergency department. | Baseline through Month 18 | |
Secondary | Mortality | Number of people who die as found in EHR and North Carolina (NC) death registry | Baseline through Month 18 | |
Secondary | Implementation Metric--Feasibility | Feasibility (FIM): This is a questionnaire that helps determine feasibility of the intervention. Score ranges from 4-20, with a higher score meaning the participant feels the intervention is more feasible. | Baseline through Month 18 | |
Secondary | Implementation Metric-- Acceptability | This is a questionnaire that helps determine acceptability of the intervention. Score ranges from 4-20, with a higher score meaning the participant feels the intervention is more acceptable. | Baseline through Month 18 | |
Secondary | Implementation Metric-- Appropriateness | This is a questionnaire that helps determine appropriateness of the intervention. Score ranges from 4-20, with a higher score meaning the participant feels the intervention is more appropriate. | Baseline through Month 18 | |
Secondary | Implementation Metric- Value | Three questions will be coded and analyzed through qualitative analysis. The study team will code comments by hand using content analysis and grounded theory. | Baseline through Month 18 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05594446 -
Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
|
||
Completed |
NCT03975309 -
DHS MIND Metabolomics
|
||
Completed |
NCT01855399 -
Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes
|
N/A | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Recruiting |
NCT05007990 -
Caregiving Networks Across Disease Context and the Life Course
|
||
Active, not recruiting |
NCT04420936 -
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program
|
N/A | |
Recruiting |
NCT03549559 -
Imaging Histone Deacetylase in the Heart
|
N/A | |
Completed |
NCT04903496 -
Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
|
||
Completed |
NCT01437592 -
Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT03390179 -
Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Recruiting |
NCT05294822 -
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes
|
N/A | |
Completed |
NCT04427982 -
Dance and Diabetes/Prediabetes Self-Management
|
N/A | |
Completed |
NCT02356848 -
STEP UP to Avert Amputation in Diabetes
|
N/A | |
Completed |
NCT03292185 -
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
|
Phase 1 | |
Active, not recruiting |
NCT05477368 -
Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes
|
N/A | |
Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 |